Safety of Tetanus, Diphtheria, Acellular Pertussis With 5 Acellular Pertussis Components (Tdap5) Vaccination During Pregnancy
Clinical trial NCT06258057 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06258057
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-01-02
- Primary completion
- 2026-12-31
- Enrollment
- 365000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.